Company intelligence / Profile preview

Anagenix

Auckland, New Zealand

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Anagenix develops and markets clinically characterized nutraceutical ingredients from New Zealand-grown fruits, supported by published trials demonstrating efficacy in digestive and gut health, particularly with products like ACTAZIN and LIVAuX[3][6].

Therapeutic areas: ImmunologyGastroenterologyInfectious DiseasesNeurologyPulmonologyMetabolic Disorders
Modalities: Live biotherapeutic product therapyMicrobial therapySmall moleculeProtein
Industry: Food & Nutrition

Partnerships

Faravelli (Italy distributor)Denk IngredientsHawkins WattsPlant & Food ResearchCallaghan InnovationRiddet InstituteUniversity of AucklandUniversity of OtagoMassey UniversityVictoria UniversityNational Science Challenge (NZ High Value Nutrition)SwisseMicrobiome LabsHolland & BarrettCulturelleAmazing Grass

Beyond the preview

Go deeper on Anagenix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anagenix.

Explore the full profile